CLINICAL RESEARCH: HEART FAILURE
Effect of kidney transplantation on left ventricular systolic dysfunction and congestive heart failure in patients with end-stage renal disease
Ravinder K. Wali, MD*,*,
Gregory S. Wang, MD ,¶,
Stephen S. Gottlieb, MD ,
Lavanya Bellumkonda, MD*,¶,
Riple Hansalia, MD,¶,
Emilio Ramos, MD*,
Cinthia Drachenberg, MD||,
John Papadimitriou, MD||,
Meredith A. Brisco, MD,¶,
Steve Blahut, PhD*,
Jeffrey C. Fink, MD*,
Michael L. Fisher, MD,¶,
Stephen T. Bartlett, MD and
Matthew R. Weir, MD*
* Division of Nephrology, Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland
Department of Internal Medicine, University of Maryland School of Medicine, Baltimore, Maryland
Division of Cardiology, Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland
Division of Transplant Surgery, Department of Surgery, University of Maryland School of Medicine, Baltimore, Maryland
|| Department of Pathology, University of Maryland School of Medicine, Baltimore, Maryland
¶ Current author affiliations: Dr. Wang, Department of Internal Medicine, Emory University School of Medicine, Atlanta, Georgia; Dr. Bellumkonda, Department of Medicine, University of Connecticut Health Center, Farmington, Connecticut; Dr. Hansalia, Zena and Michael A. Weiner Cardiovascular Institute, New York, New York; Dr. Fisher, Department of Cardiology, Kaiser Permanente, Denver, Colorado; and Dr. Brisco, Department of Internal Medicine, Barnes-Jewish Hospital, St. Louis, Missouri
Manuscript received August 25, 2004;
revised manuscript received November 23, 2004,
accepted November 29, 2004.
* Reprint requests and correspondence: Dr. Ravinder K. Wali, University of Maryland School of Medicine, Department of Medicine, Division of Nephrology, N3W143, 22 South Greene Street, Baltimore, Maryland 21201 (Email: rwali{at}medicine.umaryland.edu).
OBJECTIVES: We examined the impact of kidney transplantation on left ventricular ejection fraction (LVEF) in end-stage renal disease (ESRD) patients with congestive heart failure (CHF).
BACKGROUND: The ESRD patients with decreased LVEF and a poor New York Heart Association (NYHA) functional class are not usually referred for transplant evaluations, as they are considered to be at increased risk of cardiac and surgical complications.
METHODS: Between June 1998 and November 2002, 103 recipients with LVEF  40% and CHF underwent kidney transplantation. The LVEF was re-assessed by radionuclide ventriculography gated-blood pool (MUGA) scan at six and 12 months and at the last follow-up during the post-transplant period.
RESULTS: Mean pre-transplant LVEF% increased from 31.6 ± 6.7 (95% confidence interval [CI] 30.3 to 32.9) to 52.2 ± 12.0 (95% CI 49.9 to 54.6, p = 0.002) at 12 months after transplantation. There was no perioperative death. After transplantation, 69.9% of patients achieved LVEF  50% (normal LVEF). A longer duration of dialysis (in months) before transplantation decreased the likelihood of normalization of LVEF in the post-transplant period (odds ratio 0.82, 95% CI 0.74 to 0.91; p < 0.001). The NYHA functional class improved significantly in those with normalization of LVEF (p = 0.003). After transplantation, LVEF >50% was the only significant factor associated with a lower hazard for death or hospitalizations for CHF (relative risk 0.90, 95% CI 0.86 to 0.95; p < 0.0001).
CONCLUSIONS: Kidney transplantation in ESRD patients with advanced systolic heart failure results in an increase in LVEF, improves functional status of CHF, and increases survival. To abrogate the adverse effects of prolonged dialysis on myocardial function, ESRD patients should be counseled for kidney transplantation as soon as the diagnosis of systolic heart failure is established.
|
Abbreviations and Acronyms
| | ACE = angiotensin-converting enzyme | | CABG = coronary artery bypass graft | | CHF = congestive heart failure | | ESRD = end-stage renal disease | | LVEF = left ventricular ejection fraction | | MUGA = radionuclide ventriculography gated-blood pool scan | | NYHA = New York Heart Association | | PTCA = percutaneous transluminal coronary angioplasty | | PTH-I = intact parathyroid hormone | | URR = urea reduction ratio |
|
Related Article
-
Improvement of heart failure after renal transplantation: The complex maze of cardio-renal interaction
- Hector O. Ventura and Mandeep R. Mehra
J. Am. Coll. Cardiol. 2005 45: 1061-1063.
[Full Text]
[PDF]
This article has been cited by other articles:
|
|
|
|
 
F. G. Hage, R. Venkataraman, G. J. Zoghbi, G. J. Perry, A. M. DeMattos, and A. E. Iskandrian
The scope of coronary heart disease in patients with chronic kidney disease.
J. Am. Coll. Cardiol.,
June 9, 2009;
53(23):
2129 - 2140.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. V. Liang, E. L. Greene, A. W. Williams, C. A. Herzog, D. O. Hodge, T. E. Owan, and M. M. Redfield
Exploratory study of relationship between hospitalized heart failure and chronic renal replacement therapy
Nephrol. Dial. Transplant.,
January 28, 2009;
(2009)
gfn775v1.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. M. de Mattos, A. Siedlecki, R. S. Gaston, G. J. Perry, B. A. Julian, C. E. Kew II, M. H. Deierhoi, C. Young, J. J. Curtis, and A. E. Iskandrian
Systolic Dysfunction Portends Increased Mortality among Those Waiting for Renal Transplant
J. Am. Soc. Nephrol.,
June 1, 2008;
19(6):
1191 - 1196.
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Sharma, E. Chemla, M. Tome, R. L Mehta, H. Gregson, S. J D Brecker, R. Chang, and D. Pellerin
Echocardiography-based score to predict outcome after renal transplantation
Heart,
April 1, 2007;
93(4):
464 - 469.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. N. DeMaria, O. Ben-Yehuda, D. Berman, G. K. Feld, G. S. Ginsburg, B. H. Greenberg, W. Y.W. Lew, D. Sahn, and S. Tsimikas
Highlights of the Year in JACC 2005
J. Am. Coll. Cardiol.,
January 3, 2006;
47(1):
184 - 202.
[Full Text]
[PDF]
|
|
|
|
